Open Access
- 5 May 2026
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 229 (4) , 1-4
Abstract
Summary: Lithium is the only true mood stabiliser as it is able to both treat and prevent mania and depression. In practice, its popularity has declined despite discovering it has anti-suicidal and neuroprotective properties. Here, we argue for recognition of its benefits and advocate for its clinical use more widely.Keywords
This publication has 9 references indexed in Scilit:
- Lithium as a disease-modifying drug for bipolar disorderThe Lancet Psychiatry, 2025
- Prevention of suicidal behavior with lithium treatment in patients with recurrent mood disordersInternational Journal of Bipolar Disorders, 2024
- Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta‐analysesActa Psychiatrica Scandinavica, 2020
- Monotherapy vs. combination therapy for post mania maintenance treatment: A population based cohort studyEuropean Neuropsychopharmacology, 2019
- Impact of Long-Term Lithium Treatment on Renal Function in Patients With Bipolar Disorder Based on Novel BiomarkersJournal of Clinical Psychopharmacology, 2019
- Long-term effect of lithium maintenance therapy on estimated glomerular filtration rate in patients with affective disorders: a population-based cohort studyThe Lancet Psychiatry, 2015
- The king is dead, long live the king! The restoration of BALANCEBipolar Disorders, 2010
- Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trialThe Lancet, 2010
- THE TREATMENT OF MANIC PSYCHOSES BY THE ADMINISTRATION OF LITHIUM SALTSJournal of Neurology, Neurosurgery & Psychiatry, 1954